Table 1. Transfusion requirements from day of last dose of study drug to CABG.

Variable	<5 Days			6-7 Days			>7 Days
	Prasugrel (n = 88)	Clopidogrel (n = 99)	P value*	Prasugrel (n = 34)	Clopidogrel (n = 41)	P value*	Prasugrel (n = 50)	Clopidogrel (n = 32)	P value*
Intraoperative
RBCs	0.62 ± 1.14	0.84 ± 1.14	.098	0.71 ± 1.69	0.59 ± 1.04	.945	0.34 ± 0.67	0.79 ± 1.91	.664
Platelets	0.33 ± 1.20	0.22 ± 1.13	.300	0 ± 0	0.05 ± 0.32	.358	0.23 ± 1.46	0.29 ± 1.19	.669
THCs	0.77 ± 2.24	0.47 ± 1.56	.267	0.09 ± 0.38	0.10 ± 0.45	.887	0.30 ± 1.49	0.74 ± 2.25	.485
TDE	1.40 ± 2.64	1.30 ± 1.98	.511	0.80 ± 1.89	0.69 ± 1.08	.671	0.64 ± 1.65	1.53 ± 3.87	.974
Postoperative
RBCs	2.02 ± 3.34	1.27 ± 1.77	.120	1.82 ± 2.44	0.92 ± 1.60	.154	1.06 ± 1.69	0.84 ± 1.24	.627
Platelets	0.95 ± 2.84	0.25 ±1.14	.018	0.18 ± 0.53	0.08 ± 0.48	.127	0.15 ± 0.87	0.23 ± 1.09	.653
THCs	2.31 ± 5.81	0.72 ± 2.09	.155	1.48 ± 3.13	0.64 ± 3.41	.006	0.75 ± 1.80	0.68 ± 1.83	.858
TDE	4.34 ± 8.45	1.99 ± 3.28	.267	3.30 ± 5.14	1.56 ± 4.71	.107	1.81 ± 3.23	1.52 ± 2.71	.504
Total
RBCs	2.64 ± 3.91	2.11 ± 2.24	.594	2.53 ± 2.96	1.51 ± 1.83	.297	1.40 ± 1.94	1.63 ± 2.69	.847
Platelets	1.25 ± 3.25	0.47 ± 1.57	.039	0.18 ± 0.53	0.13 ± 0.57	.322	0.38 ± 1.67	0.52 ± 2.25	.793
THCs	3.08 ± 6.56	1.18 ± 2.51	.194	1.58 ± 3.20	0.74 ± 3.42	.036	1.04 ± 2.52	1.42 ± 3.88	.888
TDE	5.71 ± 9.45	3.29 ± 3.91	.556	4.11 ± 5.64	2.26 ± 4.73	.349	2.44 ± 3.80	3.05 ± 5.98	.548

Data presented as mean ± standard deviation. Number of subjects included those from last day of drug to surgery. RBCs, Red blood cells (packed RBCs, whole blood); TDE, total donor exposure (RBCs, platelets, cryoprecipitate, plasma); THCs, total hemostatic components (platelets, cryoprecipitate, plasma).

^*P < .05 (Kruskal-Wallis test).